Stocksigma LogoStocksigma Logo

Natco Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 9,673 (-29.0% YoY | +31.6% QoQ) ■ EBITDA: 2,579 (-55.5% YoY | +38.3% QoQ) ■ EBITDA Margin (%): 26.7 (-1583 bps YoY | +129 bps QoQ) ■ PAT: 2,026

Natco Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Natco Pharma Ltd · Outcome · 13 Nov 2026, 7:43 pm

Natco Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 9,673 (-29.0% YoY | +31.6% QoQ) ■ EBITDA: 2,579 (-55.5% YoY | +38.3% QoQ) ■ EBITDA Margin (%): 26.7 (-1583 bps YoY | +129 bps QoQ) ■ PAT: 2,026 (-60.9% YoY | -1.9% QoQ) ■ EPS (INR): 11.3 (-60.9% YoY | -1.9% QoQ) Natco Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Pharmaceuticals ■ Revenue: 9,063 (-30.8% YoY | +30.5% QoQ) ■ EBIT: 2,607 (-58.8% YoY | +27.9% QoQ) ■ EBIT Margin (%): 28.8 (-1957 bps YoY | -60 bps QoQ) Agro chemicals ■ Revenue: 610 (+16.2% YoY | +49.5% QoQ) ■ EBIT: 1.0 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 0.2 (Loss to Profit YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Natco Pharma Ltd

All Natco Pharma Ltd announcements